Virus Capture Kits
Get more from your samples and get it faster. Knowing a virus is present in a sample and not being able to detect it is frustrating. Use Nanotrap® Magnetic Virus Particles to concentrate viruses rapidly from complex biological matrices in order to have high quality input material for your downstream analytical methods.
Nanotrap® Magnetic Virus Particles demonstrated to capture and concentrate the following viruses: influenza A H1N1 (1), influenza A H3N2 (1), influenza B (1), respiratory syncytial virus A2001/3-12 (1), coronavirus 229E (1), coronavirus OC43 (2), SARS-CoV-2 (3)(4), Zika (10), and chikungunya (10).
Methods developed for clinical swab samples, saliva, and wastewater. (3)(4)(5)(7)(8)
Reduce clinical sample processing time by 2- to 3-fold by eliminating commercial extraction kit.
Enables an automated method for concentrating and processing virus from 24 wastewater samples in 40 minutes, reducing processing time by at least 20-fold, as compared to other methods. (8)
Enables pooled patient sample testing with methods developed for sample volumes up to 10 mL. (4)(6)
Eliminate false negatives. Nanotrap® particles enabled the identification of SARS-CoV-2 RNA in 9 out of 32 diagnostic remnant samples that had previously tested negative for the virus. (4)
Increase assay sensitivity by capturing and concentrating low abundance viruses. Nanotrap® particles improved the real-time RT-PCR signal in low viral load diagnostic remnant samples by an average of 3.1 Ct values. (4)
Successfully utilized in RT-PCR assays with FDA Emergency Used Authorization for COVID-19. (9)
Nanotrap® particles utilize affinity capture and enrichment to attract and bind low abundance viruses. Nanotrap® particles do not utilize antibodies or other biomolecules as affinity molecules.
Incorporating the Nanotrap® technology into your workflow is simple. Reduce your sample real-time RT-PCR sample processing time by 2-3 fold by eliminating a commercial extraction kit altogether.